Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY · Healthcare
Sector
Healthcare
Size band
Large cap
Market cap
99,854cr
P/E
21.5
ROE
20.3%
Dividend yield
0.7%
No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.
Measured against
Peer set
Pharmaceuticals & Drugs · largest 12 of 82 measured at Q1 FY27 · financials via Screener| Company | Operating margin | Revenue growth |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 29.0% | 10.5% |
| Divi's Laboratories Ltd. | 41.0% | 27.8% |
| Torrent Pharmaceuticals Ltd. | 34.0% | 54.8% |
| Lupin Ltd. | 30.0% | 32.1% |
| Dr. Reddy's Laboratories Ltd. | 11.0% | −5.5% |
| Cipla Ltd. | 17.0% | 2.3% |
| Zydus Lifesciences Ltd. | 24.0% | 22.0% |
| Mankind Pharma Ltd. | 26.0% | 12.9% |
| Aurobindo Pharma Ltd. | 21.0% | 16.3% |
| Torrent Power Ltd. | 19.0% | 2.8% |
| Alkem Laboratories Ltd. | 20.0% | 10.9% |
| Glenmark Pharmaceuticals Ltd. | 20.0% | 23.1% |
No guidance on record.
This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Dr. Reddy's Laboratories Ltd..
On air
20 calls · outcomes not trackedRecorded as stated on air, with the analyst's SEBI registration status where it was given. Anchor calls carry no registration and are marked. Bharatstox does not make, endorse or repeat these calls, and none of them is our view.
| Channel & show | Aired | Stated target | Stated stop | Outcome |
|---|---|---|---|---|
| Zee BusinessZee Business · no registration attached | 14 Oct | +2.9% | — | still open |
| Zee BusinessZee Business · no registration attached | 14 Oct | +2.9% | -2.8% | still open |
| Zee BusinessZee Business · no registration attached | 14 Oct | +3.3% | -2.5% | still open |
| Zee BusinessZee Business · no registration attached | 14 Oct | +2.7% | -3.0% | still open |
| Zee BusinessZee Business · no registration attached | 14 Oct | +3.2% | -4.0% | still open |
| Zee BusinessZee Business · no registration attached | 14 Oct | +1.6% | -4.0% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 12 Oct | +1.4% | -0.6% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 12 Oct | +1.5% | -0.6% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 12 Oct | +2.6% | -1.5% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 9 Oct | -4.4% | +1.0% | still open |
| Zee BusinessZee Business · no registration attached | 7 Oct | +2.0% | -1.3% | still open |
| Zee BusinessZee Business · no registration attached | 7 Oct | +1.6% | -1.7% | still open |
| Zee BusinessZee Business · no registration attached | 7 Oct | +3.2% | -1.7% | still open |
| CNBC AwaazCNBC Awaax · no registration attached | 7 Oct | +2.5% | -1.2% | still open |
| Zee BusinessZee Business · no registration attached | 7 Oct | +1.9% | — | still open |
| Zee BusinessZee Business · no registration attached | 7 Oct | +13.8% | — | still open |
| Zee BusinessZee Business · no registration attached | 7 Oct | +11.8% | — | still open |
| Zee BusinessZee Business · no registration attached | 1 Oct | +2.4% | -0.9% | still open |
| Zee BusinessZee Business · no registration attached | 1 Oct | +2.2% | -1.1% | still open |
| Zee BusinessZee Business · no registration attached | 1 Oct | +2.2% | — | still open |
Shareholding
change across 4 filings| Category | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Change |
|---|---|---|---|---|---|
| Promoters | 26.6 | 26.6 | 26.6 | 26.6 | 0.0 |
| Foreign institutions | 32.1 | 33.1 | 33.2 | 35.5 | −3.4 |
| Domestic institutions | 31.7 | 30.7 | 30.4 | 28.0 | +3.7 |
| Retail & others | 9.6 | 9.6 | 9.7 | 9.9 | −0.3 |
As filed with the exchange for the periods ending Sep 25 to Jun 26.
Filings
latest 25 of 494- General Updates14 Oct 2026
- General Updates8 Oct 2026
- Press Release7 Oct 2026
- Certificate under SEBI (Depositories and Participants) Regulations, 20187 Oct 2026
- Closure of Trading window22 Sept 2026
- Trading Window22 Sept 2026
- Dr Reddys Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 ,inter alia, to consider and approve Unaudited Standalone ....22 Sept 2026
- Intimation of analyst meet21 Sept 2026
- Analysts/Institutional Investor Meet/Con. Call Updates21 Sept 2026
- Arrangements for strategic, technical, manufacturing, or marketing tie up18 Sept 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 201518 Sept 2026
- News Verification18 Sept 2026
- Clarification- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 201518 Sept 2026
- The Exchange has sought clarification from Dr Reddys Laboratories Ltd on September 17, 2026, with reference to news appeared in https://pharma.economictimes.indiatimes.com/ dated September ....17 Sept 2026RoutineGeneral
- News Verification17 Sept 2026RoutineGeneral
- Copy of Newspaper Publication16 Sept 2026
- Copies of newspaper publication16 Sept 2026
- General Updates11 Sept 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 201511 Sept 2026
- General Updates10 Sept 2026
- Allotment of Employee Stock options10 Sept 2026
- Analysts/Institutional Investor Meet/Con. Call Updates10 Sept 2026
- Intimation of Analyst meet10 Sept 2026
- General Updates26 Aug 2026
- Allotment of Employee Stock options26 Aug 2026
The 25 most recent of 494 filings we hold for DRREDDY, back to January 2024. Every filing, by day.
Disclaimer
Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Broadcast calls are reproduced as stated on air, attributed, with the analyst's SEBI registration status where given; they are not our calls and not our view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.